Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cellsXiangnan Guan, Namrata S. Patil, Eugene Y. Chiang et al.|Nature|2024Cited by 121
LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody–Induced Tumor Cell Killing by Effector CD8+ T CellsAeRyon Kim, Xin Yu, Chia-Jung Han et al.|The Journal of Immunology|2019Cited by 45
Abstract PR004: Cancer cell intrinsic SSBP4 enables tumor immune evasion by promoting cholesterol biosynthesisP. Ou, Xin Yu, Ittai Eres et al.|Cancer Immunology Research|2025Cited by 0